Cargando…

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series

Children diagnosed with high grade gliomas (HGG) have dismal prognoses and treatment options remain limited. Tumor treating fields (TTFields) in combination with temozolomide (TMZ) is approved for the treatment of newly diagnosed and recurrent glioblastoma (GBM) in adult patients. However, clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crawford, John, Saria, Marlon G, Dhall, Girish, Margol, Ashley, Kesari, Santosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641478/ https://www.ncbi.nlm.nih.gov/pubmed/33163308 http://dx.doi.org/10.7759/cureus.10804

Ejemplares similares

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data
por: Goldman, Stewart, et al.
Publicado: (2022)

ATRT-30. RETROSPECTIVE ANALYSIS OF CHILDREN WITH ATYPICAL TERATOID RHABDOID TUMOR TREATED ACCORDING TO ACNS0333
por: Hoffman, Lindsey, et al.
Publicado: (2020)

Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas
por: Segar, David J., et al.
Publicado: (2023)

Tumor Treating Fields in the Management of Patients with Malignant Gliomas
por: Ghiaseddin, Ashley P., et al.
Publicado: (2020)

The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
por: Krigers, Aleksandrs, et al.
Publicado: (2022)

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022)

Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields
por: Liu, Shiyu, et al.
Publicado: (2021)

Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
por: Toll, Stephanie A., et al.
Publicado: (2019)

Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
por: Toll, Stephanie A., et al.
Publicado: (2023)

Author Correction: Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas
por: Segar, David J., et al.
Publicado: (2023)

The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges
por: Ekhator, Chukwuyem, et al.
Publicado: (2022)

The Impacts of Tumor and Tumor Associated Epilepsy on Subcortical Brain Structures and Long Distance Connectivity in Patients With Low Grade Glioma
por: Bouwen, Bibi L. J., et al.
Publicado: (2018)

Predictors of Seizure Freedom in Pediatric Low-Grade Gliomas
por: Budnick, Hailey C, et al.
Publicado: (2022)

Application of intraoperative ultrasound in the resection of high-grade gliomas
por: Wei, RenJie, et al.
Publicado: (2023)

Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas
por: Ankush, Ankush, et al.
Publicado: (2022)

Effectiveness and safety of tumor-treating fields therapy for glioblastoma: A single-center study in a Chinese cohort
por: She, Lei, et al.
Publicado: (2023)

Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study
por: Lu, Guangrong, et al.
Publicado: (2019)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Radiation Therapy for Grade 3 Gliomas: Correlation of MRI Findings With Prognosis
por: Mizumoto, Masashi, et al.
Publicado: (2021)

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma
por: van Kessel, Emma, et al.
Publicado: (2021)

Neuropsychiatric and Neurocognitive Manifestations in HIV-Infected Children Treated With Efavirenz in South Africa—A Retrospective Case Series
por: Hammond, Charles K., et al.
Publicado: (2019)

Is re-radiation for glioblastoma after progression associated with increased survival: to treat or not to treat?
por: Carrillo, Jose A., et al.
Publicado: (2019)

A RADIATION ONCOLOGIST’S EXPERIENCE TREATING MALIGNANT GLIOMA WITH TUMOR TREATING FIELDS IN CANADA
por: Roberge, David, et al.
Publicado: (2023)

Treating Aggression and Self-destructive Behaviors by Stimulating the Nucleus Accumbens: A Case Series
por: Harat, Marek, et al.
Publicado: (2021)

Biological activity of tumor-treating fields in preclinical glioma models
por: Silginer, Manuela, et al.
Publicado: (2017)

MEDB-86. A re-induction regimen for children with recurrent medulloblastoma
por: O'Halloran, Katrina, et al.
Publicado: (2022)

Risk Assessment by Pre-surgical Tractography in Left Hemisphere Low-Grade Gliomas
por: Ius, Tamara, et al.
Publicado: (2021)

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2020)

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series
por: De Mercanti, Stefania F., et al.
Publicado: (2021)

The First Case Series From Japan of Primary Headache Patients Treated by Completely Online Telemedicine
por: Katsuki, Masahito
Publicado: (2022)

Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
por: Loya, Joshua, et al.
Publicado: (2019)

Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
por: Alva, Elizabeth, et al.
Publicado: (2023)

High-Dose Fluorescein Reveals Unusual Confocal Endomicroscope Imaging of Low-Grade Glioma
por: Belykh, Evgenii, et al.
Publicado: (2021)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
por: Zhang, Qiang, et al.
Publicado: (2021)

Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022)

Bevacizumab is associated with cerebral microstructural alterations: a DTI study in high-grade glioma
por: Kassubek, Rebecca, et al.
Publicado: (2023)

Serum microRNA-4297 is a sex-specific predictive biomarker of glioma grade and prognosis
por: Xu, Wenshen, et al.
Publicado: (2022)

Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2021)

Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines
por: Panigrahy, Ashok, et al.
Publicado: (2022)

Prognostic Value and Risk Factors of Treatment-Related Lymphopenia in Malignant Glioma Patients Treated With Chemoradiotherapy: A Systematic Review and Meta-Analysis
por: Zhang, Yongchao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6hqd1cevmckikgld1s925p3k9g